WitrynaImpel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity... WitrynaImpel Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IMPL updated stock price target summary.

Impel Pharmaceuticals NasdaqGM:IMPL Stock Report - Simply …

WitrynaIMPEL NEUROPHARMA, INC. (Exact name of Registrant as specified in its charter) Delaware : 26-3058238 (State or other jurisdiction of ... (Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices) 2024 Equity Incentive Plan . 2024 Employee Stock Purchase Plan . 2024 Equity Incentive ... WitrynaThis presentation and the accompanying oral commentary by Impel NeuroPharma, Inc. (“we,” “us,” “our,” “Impel” or the “Company”) contains forward-looking statements that … east hardy football radio broadcast

Impel NeuroPharma - Products, Competitors, Financials, …

WitrynaImpel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high … Witryna1 mar 2024 · Impel NeuroPharma, Inc. is a privately held, Seattle -based pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize … Witryna11 kwi 2024 · Corporate Profile. Impel Pharmaceuticals is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules … cullyhanna pharmacy